Sanlin Robinson
Manager of Product Development at 3D Systems Corporation
Littleton, Colorado
Overview
Work Experience
Product Development, Manager
2023 - Current
Drive execution of the strategic roadmap to ensure product development milestones, regulatory deliverables, and commercial objectives are consistently met. Lead and develop a high-performing team of engineers and technicians, embedding design controls and best-in-class development practices while fostering a culture of accountability, innovation, and professional growth. Partner cross-functionally with customers and orthopedic surgeons, as well as business development, quality, manufacturing, and regulatory teams to accelerate products from concept to commercialization. Own end-to-end execution of 10+ high-value initiatives, aligning technical strategy with organizational priorities to deliver scalable, market-ready solutions. In a single year, led my team to secure four 510(k) clearances and transfer seven new product lines into full-scale production—driving both regulatory success and manufacturing readiness. Certified to Medical Device Design Control: FDA, ISO 13485
3D Systems provides 3D content-to-print solutions such as printers, print materials, custom parts, and imaging and customization software.
Raised $264,187,440.00 from PNC Bank.
Assistant Professor of Engineering
2021 - 2023
Spearheaded the launch of a new engineering concentration within the Physics B.S. program, contributing to curriculum design, grant development, and recruitment strategy to align with institutional growth objectives. Developed and delivered core engineering and physics courses, including Statics and Introduction to Engineering, strengthening the university’s technical education portfolio. Founded and advised the university’s first Society of Women Engineers chapter, fostering a culture of inclusion, leadership, and professional development. Appointed to the College of Science & Mathematics strategic planning committee, guiding long-term academic priorities and programmatic investments. Directed a six-student team in the technical execution of a NASA-affiliated high-altitude balloon project, integrating CAD training with hands-on payload fabrication.
Investment Associate
2020 - 2021
Conducted due diligence on early-stage technologies with a focus on R&D maturity, IP strategy, market viability, and competitive positioning to inform investment decisions. Evaluated 50+ startups across deep tech and life sciences; five companies received investment following my analysis and recommendations to managing partners. Applied scientific expertise to assess technology feasibility, team strength, and risk—enabling data-driven, high-conviction decision making. Led development of the firm’s ESG evaluation and reporting framework, aligning portfolio strategy with UN Principles for Responsible Investment. Actively managed a four-company portfolio, maintaining strong relationships with founders, producing quarterly performance reports, and advising on milestones for future funding rounds.
Safar Partners is a seed- to growth-stage venture fund.
Postdoctoral Fellow in Lewis Lab
2017 - 2020
Led the design and development of a next-generation kidney-on-chip platform, engineered for enhanced throughput and statistical power in drug screening and disease modeling. Platform remains in active use 5+ years later. Managed scientific communications and stakeholder engagement, including biannual funding reports, monthly presentations, and collaborative initiatives with industry partners. Mentored and trained seven researchers, fostering technical skill-building and professional development across disciplines. Awarded the Organ Design & Engineering Postdoctoral Training Fellowship by Harvard Medical School and Brigham & Women’s Hospital (2018–2019), in recognition of high-impact research and translational innovation.
Graduate Research Associate
2011 - 2017
Graduate Research Associate, 2016-2017 Graduate Research Teaching Assistant, 2013 Graduate Research Assistant, 2011-2015 Spearheaded three high-impact research projects from conception through publication, overseeing technology development, experimental design, data analysis, and stakeholder communication. Delivered results that advanced the understanding of soft materials and their biomedical applications. Led the design and development of patient-specific cardiac implants, utilizing additive manufacturing to create anatomically accurate medical devices for diverse patient morphologies. Optimized design workflows that enabled rapid prototyping of custom implants in under 12 hours, dramatically reducing development timelines and increasing clinical applicability. Directed and managed interdisciplinary teams, mentoring 15+ students across various levels, cultivating their research and technical skills while overseeing the integration of experimental techniques and safety protocols. Pioneered the design of soft, capacitive skins for haptic feedback interfaces, enabling the first demonstration of a fully soft, feedback-controlled haptic interface capable of precise, real-time sensory input—an innovation in human-machine interaction.
Medical Device R&D Trainee
2015 - 2016
Led the first animal trial for an innovative left atrial appendage stroke prevention device. This involved designing, fabricating, and performing verification testing on a silicone-based medical device. Collaborated with cross-functional teams (engineering, cardiology, radiology, veterinary surgeons) to manage all aspects of animal study logistics, data collection, and reporting, ensuring rigorous adherence to safety and regulatory standards. Successfully navigated challenges to deliver results in tight timelines.
Weill Cornell Medicine is an academic medical institution that offers health care services.
Raised $53,500,000.00 from National Cancer Institute, National Institutes of Health, UnitedHealthcare and National Institutes of Health.